REG - Accrol Group Hldgs - Director Dealing

Accrol groupAnnouncement

04/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220304:nRSD6087Da&default-theme=true

RNS Number : 6087D  Accrol Group Holdings PLC  04 March 2022

 

4 March 2022

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

Accrol Group Holdings plc

("Accrol" or the "Company")

 

Director Dealing

 

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, announces
that Dan Wright, Executive Chairman of Accrol, has purchased 1,000,000
ordinary shares of £0.001 each ("Ordinary Shares") at an average price of
19.5875p per Ordinary Share.

Following this purchase, he now holds 12,515,543* Ordinary Shares representing
approximately 3.9% of the current Issued Share Capital of the Company.

 *  10,786,972 of these shares are registered in the name of Gomrath Limited, a
    family investment company controlled by Dan Wright

The notification below, made in accordance with the requirements of the EU
Market Abuse Regulation as it forms part of UK domestic law by virtue of the
European Union (Withdrawal) Act 2018, provides further detail.

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 

 1    Details of the person discharging managerial responsibilities / person closely
      associated
 a)   Name                                                         Dan Wright
 2    Reason for the notification
 a)   Position/status                                              Executive Chairman
 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Accrol Group Holdings plc
 b)   LEI                                                          213800MC56M5G69RJ226
 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Ordinary shares of £0.001 each

      Identification code

                                                                   ISIN: GB00BZ6VT592
 b)   Nature of the transaction                                    Purchase of Ordinary Shares
 c)   Price(s) and volume(s)                                        Price(s)   Volume(s)
                                                                   19.5p       750,000

                                                                   19.85p      250,000
 d)   Aggregated information                                       1,000,000

      - Aggregated volume                                          19.5875p

      - Price
 e)   Date of the transaction                                      3 March 2022
 f)   Place of the transaction                                     London Stock Exchange, AIM

d)

Aggregated information

- Aggregated volume

- Price

1,000,000

19.5875p

e)

Date of the transaction

3 March 2022

f)

Place of the transaction

London Stock Exchange, AIM

 

 

 For further information, please contact:

 Accrol Group Holdings plc
 Dan Wright, Executive Chairman                           Via Belvedere Communications
 Gareth Jenkins, Chief Executive Officer

 Richard Newman, Chief Financial Officer

 Zeus Capital Limited (Nominated Adviser & Broker)
 Dan Bate / Jordan Warburton                              Tel: +44 (0) 161 831 1512
 Dominic King                                             Tel: +44 (0) 203 829 5000

 Liberum Capital Limited (Joint Broker)                   Tel: +44 (0) 20 3100 2222
 Clayton Bush / Edward Thomas

 Belvedere Communications Limited
 Cat Valentine                                            Tel: +44 (0) 7715 769 078
 Keeley Clarke                                            Tel: +44 (0) 7967 816 525
 Llew Angus                                               Tel:  +44 (0) 7407 023 147
                                                          accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet
tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's
leading discounters and grocery retailers across the UK. Following the recent
acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now
operates from six manufacturing sites, including four in Lancashire, which
generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk (http://www.accrol.co.uk)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFITVDIVIIF